Blue Jet Healthcare
BLUEJET · Pharma > Pharmaceuticals & Drugs Listing date: Nov. 1, 2023

Stock Price vs Company Growth
1d
8.4%
1w
15.3%
1m
13.3%
3m
15.3%
6m
57.9%
1y
129.9%
all
62.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

835 8.4%
627
969
Company Overview

Sales
1,030 Cr
Growth: 27.5%
Profit after Tax
305 Cr
Growth: 30.0%
Mid Cap
14,484 Cr
P/E: 47.4x
Industry P/E: 32.7x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 1,030
Growth 27.5%
EBITDA 36.7%
P/S 14.1x
Dividend 0.2%
P/E 47.4x
Book Value ₹ 65.3
PEG Ratio 1.7x
ROE 30.5%
P/B 12.8x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is a global, science-led, pharmaceutical company evolved as Strategic Partner for Collaboration, Development & Manufacturing of advance Pharmaceutical Intermediates and API.
Followers (1)